ARCHIVES

New Creatinine Test Raises Questions About Accuracy Of Carboplatin Dosing

This article is from The Cancer Letter archive.

Vol. 36 No. 36 | October 8, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Mauer Resigns St. Jude Director; Breslow Named DRCCA Board Chairman; Senate Considers Line Items

August 20, 1982

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

Robert Hall appointed government relations director for National Coalition for Cancer Survivorship.

April 30, 2004

Funding Opportunities

September 27, 2002

Yates Identifies “Probable”, “Potential” Core Grant Applicants

January 16, 1987

House Science Committee Chairman Questions NIH Budget Increases.

February 2, 2001